Medical Cannabis Market Report and Forecast 2025-2034

The global medical cannabis market size was valued at USD 12.65 Billion in 2024, driven by the increased legalization of cannabis across the globe. The market size is anticipated to grow at a CAGR of 24.00% during the forecast period of 2025-2034 to achieve a value of USD 108.72 Billion by 2034.

Medical Cannabis: Introduction

Cannabis, also known as marijuana, is a psychotropic drug which is derived from the cannabis plant. It is consumed within food as an extract or by smoking or vaporizing. Historically, the substance has been used medicinally by the Indian, Egyptian, Chinese, and Islamic cultures. Currently, it is finding extensive use in treating or relieving symptoms related to chronic pain, arthritis, epilepsy, Parkinson’s, Tourette’s, AIDS, and cancer, among others.

Global Medical Cannabis Market Analysis

The growth of the market is being driven by the rising legalization of marijuana for medical applications as well as a growing acceptance of the substance by potential consumers. The rising number of research and development undertakings, clinical trials, and increased product commercialization will also drive the medical cannabis market growth. Israel is a significant market in terms of research and development investments in medical marijuana.

As reported by the Medical Cannabis Research Center, a decline has been experienced in private health insurance premiums linked to legalized medical cannabis. This decline may boost investor’s confidence in the market for medical cannabis. Investors are anticipated to accept this trend as a positive indicator of the industry's economic viability and potential for growth. The observed financial benefits associated with medical cannabis could attract increased funding from investors, which may further result in escalated support for research, development, and increased initiatives within the market and contribute to the global medical cannabis market share.

The country has led multiple pioneering studies in the field including the effect of medicinal cannabis on autistic people. Several American companies are showing interest in conducting research on the usage of cannabis in the medical sector to treat other medical conditions but due to the strict regulations of regulatory authorities like the National Institute on Drug Abuse and the Drug Enforcement Agency in the United States, the market expansion is getting hindered. Due to this situation, American companies are now conducting research in Israel and investing in the Israeli cannabis market.

Global Medical Cannabis Market Segmentations

Market Breakup by Product Type

• Buds/Marijuana Flower
• Cannabis Extracts

Market Breakup by Application

• Chronic Pain
• Mental Disorders
• Cancer
• Others

Market Breakup by End User

• Pharmaceutical
• Research and Development Centres

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Medical Cannabis Market Overview

With the increased legalization of cannabis in the medical sector, it is now used to treat a variety of conditions and symptoms including cancer, epilepsy, depression, arthritis, glaucoma, multiple sclerosis, Alzheimer's, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), post-traumatic stress disorder (PTSD), Parkinson's, and Tourette's syndrome, among others. This expanded application of cannabis to treat a variety of medical conditions is the primary factor driving the global medical cannabis market growth.

Cannabis has been authorized for medical usage in various nations due to its therapeutic advantages, with varied degrees of regulatory restrictions. Compared to other therapy alternatives, cannabis is safe and has mild side-effects. It is also used with other therapies to boost their effectiveness or minimize undesirable side effects. For instance, medical cannabis helps with nausea relief and appetite stimulation in chemotherapy patients. It is also combined with conventional opioid medicines to provide patients with pain relief while considerably reducing the amount and frequency of opioids.

North America is the leading region due to the thriving cannabis market in the United States. The regional market growth is being aided by the legalization drives for the drug for both medical and recreational purposes. With over 60% of the population in the region residing in areas with legalized medical cannabis, the market is expected to witness robust growth during the forecast period. In Canada, the overall market, including medical and legal along with illegal products, is expected to generate extensive sales revenue with a significant contribution to medical sales. The medical cannabis market size in Canada is being driven by increased legalization and the willingness of consumers to spend more on legal products. In the Europe medical cannabis market, Germany represents a key market with substantial imports from Canada.

Global Medical Cannabis Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Aurora Marijuana Inc.
• Canopy Growth Corporation
• Cronos Group Inc
• Medical Marijuana, Inc.
• OrganiGram Holding Inc.
• Terra Tech Corp.
• Tikun Olam Ltd.
• Tilray, Inc.
• VIVO Cannabis Inc.
• Medmen Enterprise Inc.
• Stenocare
• Trulieve
• GW Pharmaceuticals plc.
• Cannabis Sativa, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
*Please Note:* The report will take 5 business days to complete, after order confirmation. Show more